Type 2 Diabetes
Research from University of Pittsburgh in type 2 diabetes provides new insights
Published in Blood Weekly, February 4th, 2010
According to recent research published in the journal Pharmacotherapy, "Liraglutide, a new glucagon-like peptide-1 (GLP-1)-receptor agonist with 97% homology to human GLP-1, can be administered once/day independent of meals in patients with type 2 diabetes mellitus. Clinical trials have demonstrated its efficacy in controlling hyperglycemia, helping patients achieve hemoglobin A(1c) level goals; in facilitating weight loss, and in improving indexes of beta-cell function when used alone or in combination with metformin, glimepiride, or rosiglitazone."
"These studies also suggest that liraglutide may be associated with modest improvements in systolic blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-02-04)
More Articles from Blood Weekly
- BioMed Central
Fish oil not snake oil - Columbia University Medical Center
Columbia researchers show link between lung disease and heart function - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
New way to generate abundant functional blood vessel cells from human stem cells discovered - Southwest Foundation for Biomedical Research
Llama proteins could play a vital role in the war on terror - 4SC AG
4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203 - Acute Respiratory Distress Syndrome
Study results from S. Towfigh and colleagues update understanding of acute respiratory distress syndrome - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
